Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study (Q24811445)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

Somnuek Sungkanuparph

4

object named as

Somnuek Sungkanuparph

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

author name string

Weerawat Manosuthi

1

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Nopphanath Chumpathat

2

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Achara Chaovavanich

3

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

language of work or name

0 references

publication date

24 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

1

0 references

67

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

7 April 2017

Priority strategies for sustainable fight against HIV/AIDS in low-income countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Nevirapine in the treatment of HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Developing a human immunodeficiency virus/acquired immunodeficiency syndrome therapeutic research agenda for resource-limited countries: a consensus statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus*1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Inter-subject and ethnic differences in paracetamol metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 September 2017

Systemic antifungal agents. Drug interactions of clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

30 May 2018

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naïve patients with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-67

21 January 2018

Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 November 2018

Greater hepatic vulnerability after alcohol intake in African Americans compared with Caucasians: a population-based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 November 2018

A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 November 2018

High hepatotoxicity rate seen among HAART patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1199598

28 November 2018

[Non-nucleoside reverse transcriptase inhibitors]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16120209

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16120209

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-5-67

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

Dimensions Publication ID

0 references

release_hudgvl53xjdftnhjkofmjh5bdy

1 reference

https://api.fatcat.wiki/v0/release/hudgvl53xjdftnhjkofmjh5bdy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24811445&oldid=2177005453"